LATEST ISSUE
May/June 2026
Prescription drug prices and national priorities vary widely across the globe, leaving patients with uneven access to potentially life-changing treatments. How can health economics and outcomes research help healthcare stakeholders negotiate lower costs for countries and households without compromising pharmaceutical innovation?
